Nucleozin is primarily investigated for its antiviral properties, particularly against RNA viruses. It has shown potent activity in inhibiting the replication of influenza viruses by targeting the viral nucleoprotein, which plays a critical role in viral RNA transcription and assembly. This mechanism disrupts the virus’s ability to propagate within host cells, making Nucleozin a promising candidate for development as a broad-spectrum antiviral agent. Research also suggests potential efficacy against other viruses that rely on similar nucleoprotein functions, positioning Nucleozin as a valuable tool in antiviral drug discovery and pandemic preparedness.